FI110322B - Menetelmä valmistaa terapeuttisesti aktiivista tioalkyylitiokefalosporiinijohdannaista - Google Patents

Menetelmä valmistaa terapeuttisesti aktiivista tioalkyylitiokefalosporiinijohdannaista Download PDF

Info

Publication number
FI110322B
FI110322B FI913458A FI913458A FI110322B FI 110322 B FI110322 B FI 110322B FI 913458 A FI913458 A FI 913458A FI 913458 A FI913458 A FI 913458A FI 110322 B FI110322 B FI 110322B
Authority
FI
Finland
Prior art keywords
mmol
acyl
mixture
ethyl acetate
stirred
Prior art date
Application number
FI913458A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI913458A0 (fi
FI913458A (fi
Inventor
Tadatoshi Kubota
Masaharu Kume
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of FI913458A0 publication Critical patent/FI913458A0/fi
Publication of FI913458A publication Critical patent/FI913458A/fi
Priority to FI961610A priority Critical patent/FI961610A/fi
Application granted granted Critical
Publication of FI110322B publication Critical patent/FI110322B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI913458A 1990-07-19 1991-07-18 Menetelmä valmistaa terapeuttisesti aktiivista tioalkyylitiokefalosporiinijohdannaista FI110322B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI961610A FI961610A (fi) 1990-07-19 1996-04-12 Tioalkyylitiokefalosporiinijohdannaiset

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP19188990 1990-07-19
JP19188990 1990-07-19
JP28977290 1990-10-25
JP28977290 1990-10-25
JP31957890 1990-11-21
JP31957890 1990-11-21
JP14735791 1991-06-19
JP14735791 1991-06-19

Publications (3)

Publication Number Publication Date
FI913458A0 FI913458A0 (fi) 1991-07-18
FI913458A FI913458A (fi) 1992-01-20
FI110322B true FI110322B (fi) 2002-12-31

Family

ID=27472779

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913458A FI110322B (fi) 1990-07-19 1991-07-18 Menetelmä valmistaa terapeuttisesti aktiivista tioalkyylitiokefalosporiinijohdannaista

Country Status (22)

Country Link
US (2) US5214037A (ru)
EP (2) EP0594263B1 (ru)
JP (1) JP2618119B2 (ru)
KR (1) KR100203726B1 (ru)
CN (1) CN1034504C (ru)
AT (2) ATE181066T1 (ru)
AU (1) AU634074B2 (ru)
CA (2) CA2359026A1 (ru)
DE (2) DE69103490T2 (ru)
DK (2) DK0467647T3 (ru)
ES (1) ES2062688T3 (ru)
FI (1) FI110322B (ru)
HU (2) HU222727B1 (ru)
IE (1) IE65926B1 (ru)
IL (1) IL98745A (ru)
MX (1) MX9100227A (ru)
NO (1) NO178544C (ru)
NZ (1) NZ238838A (ru)
PH (1) PH31091A (ru)
PL (3) PL167099B1 (ru)
PT (1) PT98362B (ru)
RU (2) RU2071963C1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100576A (en) * 1991-01-18 1995-11-27 Eli Lilley And Company Cephalosporin antibiotics
EP0581552B1 (en) * 1992-07-31 1998-04-22 Shionogi & Co., Ltd. Triazolylthiomethylthio cephalosporin hyrochloride, its crystalline hydrate and the production of the same
JP3238209B2 (ja) * 1992-09-30 2001-12-10 塩野義製薬株式会社 チオメチルチオカルバセファロスポリン誘導体
KR100377559B1 (ko) * 1998-08-31 2003-03-26 주식회사 엘지생명과학 경구투여 가능한 세팔로스포린계 화합물 및 이의 제조방법
CA2287663C (en) * 1998-11-02 2008-04-08 Isao Kurimoto Process for producing 2-alkylidene-4-bromoacetoacetic acid ester
DE69911348T2 (de) 1998-11-12 2004-07-15 Shionogi & Co., Ltd. Herstellung von Derivaten von 2-Aminothiazol Hydrobromid Z-Isomeren
JP2004512266A (ja) * 2000-06-28 2004-04-22 エルジー・ライフ・サイエンシーズ・リミテッド 新規なセファロスポリン化合物およびその製造方法
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030076759A (ko) * 2002-03-21 2003-09-29 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조 방법
CN1816518A (zh) * 2003-07-10 2006-08-09 先灵公司 由3－酮链烷酸酯制备和纯化2－(烷氧基亚烷基)－3－酮链烷酸酯的方法
RU2277908C1 (ru) * 2005-11-25 2006-06-20 Закрытое акционерное общество "БиоАргоФарм" Водорастворимое средство, обладающее противовирусной активностью, на основе соединения серебра с цистином и способ его получения
CN103193731B (zh) * 2012-01-09 2015-04-22 华东理工大学 一种制备顺式-2-(2-叔丁氧甲酰胺基噻唑-4-基)-2-戊烯酸的方法
CN106831639B (zh) * 2016-12-31 2019-03-19 山东金城柯瑞化学有限公司 头孢卡品侧链酸的制备方法
EP3727673A4 (en) * 2017-12-22 2021-10-27 Illumina Inc. CATALYTIC INGREDIENTS
CN108440442A (zh) * 2018-05-08 2018-08-24 湖北凌晟药业有限公司 一种bapa的合成方法
EP4366295A2 (en) 2018-10-04 2024-05-08 Samsung Electronics Co., Ltd. Method and system for recording a super slow motion video in a portable electronic device
CN111395694A (zh) * 2020-04-09 2020-07-10 安徽扬子地板股份有限公司 一种基于石墨烯的防霉导热地板

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595995A1 (de) * 1966-04-23 1970-02-12 Merck Ag E Fungizides Mittel
US4482565A (en) * 1980-02-22 1984-11-13 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
GB8314803D0 (en) * 1983-05-27 1983-07-06 Hoechst Uk Ltd 7-oxo-4-thia-1 azabicyclo 3.2.0 heptene derivatives
US4812562A (en) * 1985-07-25 1989-03-14 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4921953A (en) * 1988-02-18 1990-05-01 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives

Also Published As

Publication number Publication date
HUT60274A (en) 1992-08-28
DE69103490D1 (de) 1994-09-22
EP0594263B1 (en) 1999-06-09
IE912321A1 (en) 1992-01-29
PT98362B (pt) 1999-01-29
AU634074B2 (en) 1993-02-11
RU2060993C1 (ru) 1996-05-27
DE69103490T2 (de) 1994-12-15
ES2062688T3 (es) 1994-12-16
DE69131325D1 (de) 1999-07-15
CN1058595A (zh) 1992-02-12
FI913458A0 (fi) 1991-07-18
CA2047347A1 (en) 1992-01-20
NZ238838A (en) 1992-08-26
DE69131325T2 (de) 1999-12-02
HU222727B1 (hu) 2003-09-29
US5214037A (en) 1993-05-25
HU912409D0 (en) 1991-12-30
AU8110291A (en) 1992-01-23
KR100203726B1 (ko) 1999-06-15
PH31091A (en) 1998-02-05
NO912821L (no) 1992-01-20
EP0467647B1 (en) 1994-08-17
CA2359026A1 (en) 1992-01-20
NO178544B (no) 1996-01-08
FI913458A (fi) 1992-01-20
PL291129A1 (en) 1992-04-06
PL167091B1 (pl) 1995-07-31
PL167119B1 (pl) 1995-07-31
MX9100227A (es) 1993-01-01
JPH0559066A (ja) 1993-03-09
IL98745A0 (en) 1992-07-15
US5352792A (en) 1994-10-04
IE65926B1 (en) 1995-11-29
CA2047347C (en) 2002-03-19
NO912821D0 (no) 1991-07-18
PL167099B1 (en) 1995-07-31
RU2071963C1 (ru) 1997-01-20
NO178544C (no) 1996-04-17
DK0467647T3 (da) 1994-12-05
DK0594263T3 (da) 1999-11-15
CN1034504C (zh) 1997-04-09
ATE181066T1 (de) 1999-06-15
PT98362A (pt) 1992-05-29
JP2618119B2 (ja) 1997-06-11
IL98745A (en) 1997-03-18
EP0467647A2 (en) 1992-01-22
EP0467647A3 (en) 1992-08-12
KR920002609A (ko) 1992-02-28
ATE110081T1 (de) 1994-09-15
EP0594263A1 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
FI110322B (fi) Menetelmä valmistaa terapeuttisesti aktiivista tioalkyylitiokefalosporiinijohdannaista
EP0136721B1 (en) Carboxyalkenamidocephalosporins
IE852071L (en) Cephalosporins
KR870002166B1 (ko) 항박테리아 화합물의 제조방법
EP0153709B1 (en) Novel cephalosporin derivatives
US4943567A (en) Cephalosporin compound and pharmaceutical composition thereof
CZ108998A3 (cs) Cefalosporinové deriváty a jejich použití jako antibiotik
EP0216385A2 (en) Antibacterial compounds
US5362724A (en) Thioalkylthio carbacephalosporin derivatives
US4665066A (en) 3-thiazolomethyl cephalosporins as antibiotics
EP0249170B1 (en) Cephem compounds, their production and use
FI66006C (fi) Foerfarande foer framstaellning av 7-(2-(2-imino-3-hydroxi-4-tiazolin-4-yl)-acetamido)cefalosporiner anvaendbara saosom anibiotika
KR960004943B1 (ko) 세펨 화합물, 이의 제조방법 및 항균제
PL167135B1 (pl) Sposób wytwarzania nowych pochodnych tioalkilotiocefalosporyny
JPH05148272A (ja) カルボキシビニルオキシイミノセフアロスポリン類
JPH0830069B2 (ja) 抗菌性化合物